Patents by Inventor Kimberly Long

Kimberly Long has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFB1 INHIBITORS AND USE THEREOF
    Publication number: 20240016928
    Abstract: Disclosed herein are therapeutic use of isoform-specific, context-permissive inhibitors of TGF?1 in the treatment of disease that involve TGF?1 dysregulation.
    Type: Application
    Filed: August 1, 2023
    Publication date: January 18, 2024
    Inventors: Thomas Schurpf, Abhishek Datta, Gregory J. Carven, Constance Martin, Ashish Kalra, Kimberly Long, Alan Buckler
  • TGFbeta1-BINDING IMMUNOGLOBULINS AND USE THEREOF
    Publication number: 20230348583
    Abstract: Disclosed herein are immunoglobulins, such as antibodies, and antigen binding portions thereof, that specifically bind complexes of GARP-TGF?1, LTBP1-TGF?1, LTBP3-TGF?1, and/or LRRC33-TGF?1. The application also provides methods of use of these immunoglobulins for, for example, inhibiting TGF?1 activity, and treating subjects suffering from TGF?1-related disorders, such as cancer and fibrosis.
    Type: Application
    Filed: March 31, 2023
    Publication date: November 2, 2023
    Inventors: Thomas SCHURPF, Gregory J. CARVEN, Abhishek DATTA, Kimberly LONG
  • TGF?1-binding immunoglobulins and use thereof
    Patent number: 11643459
    Abstract: Disclosed herein are immunoglobulins, such as antibodies, and antigen binding portions thereof, that specifically bind complexes of GARP-TGF?1, LTBP1-TGF?1, LTBP3-TGF?1, and/or LRRC33-TGF?1. The application also provides methods of use of these immunoglobulins for, for example, inhibiting TGF?1 activity, and treating subjects suffering from TGF?1-related disorders, such as cancer and fibrosis.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: May 9, 2023
    Assignee: Scholar Rock, Inc.
    Inventors: Thomas Schurpf, Gregory J. Carven, Abhishek Datta, Kimberly Long
  • USE OF MYOSTATIN INHIBITORS AND COMBINATION THERAPIES
    Publication number: 20210283166
    Abstract: The present disclosure relates to the treatment of muscle conditions, such as SMA, with the use of an agent that inhibits myostatin signaling. The disclosure includes combination therapies that include a myostatin inhibitor and a neuronal corrector.
    Type: Application
    Filed: February 3, 2021
    Publication date: September 16, 2021
    Inventors: Kimberly LONG, Adriana DONOVAN, Yung CHYUNG, Michelle STRAUB
  • Use of myostatin inhibitors and combination therapies
    Patent number: 10946036
    Abstract: The present disclosure relates to the treatment of muscle conditions, such as SMA, with the use of an agent that inhibits myostatin signaling. The disclosure includes combination therapies that include a myostatin inhibitor and a neuronal corrector.
    Type: Grant
    Filed: June 13, 2017
    Date of Patent: March 16, 2021
    Assignee: Scholar Rock, Inc.
    Inventors: Kimberly Long, Adriana Donovan, Yung Chyung, Michelle Straub
  • USE OF MYOSTATIN INHIBITORS AND COMBINATION THERAPIES
    Publication number: 20190255093
    Abstract: The present disclosure relates to the treatment of muscle conditions, such as SMA, with the use of an agent that inhibits myostatin signaling. The disclosure includes combination therapies that include a myostatin inhibitor and a neuronal corrector.
    Type: Application
    Filed: June 13, 2017
    Publication date: August 22, 2019
    Inventors: Kimberly Long, Adriana Donovan, Yung Chyung, Michelle Straub
  • ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFB1 INHIBITORS AND USE THEREOF
    Publication number: 20190209682
    Abstract: Disclosed herein are therapeutic use of isoform-specific, context-permissive inhibitors of TGF?1 in the treatment of disease that involve TGF?1 dysregulation.
    Type: Application
    Filed: March 22, 2019
    Publication date: July 11, 2019
    Inventors: Thomas Schurpf, Abhishek Datta, Gregory J. Carven, Constance Martin, Ashish Kalra, Kimberly Long, Alan Buckler
  • TGFbeta1-BINDING IMMUNOGLOBULINS AND USE THEREOF
    Publication number: 20190071493
    Abstract: Disclosed herein are immunoglobulins, such as antibodies, and antigen binding portions thereof, that specifically bind complexes of GARP-TGF?1, LTBP1-TGF?1, LTBP3-TGF?1, and/or LRRC33-TGF?1. The application also provides methods of use of these immunoglobulins for, for example, inhibiting TGF?1 activity, and treating subjects suffering from TGF?1-related disorders, such as cancer and fibrosis.
    Type: Application
    Filed: March 10, 2017
    Publication date: March 7, 2019
    Inventors: Thomas Schurpf, Gregory J. Carven, Abhishek Datta, Kimberly Long
  • ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFB1 INHIBITORS AND USE THEREOF
    Publication number: 20180207267
    Abstract: Disclosed herein are therapeutic use of isoform-specific, context-permissive inhibitors of TGF?1 in the treatment of disease that involve TGF?1 dysregulation.
    Type: Application
    Filed: January 5, 2018
    Publication date: July 26, 2018
    Inventors: Thomas Schurpf, Abhishek Datta, Gregory J. Carven, Constance Martin, Ashish Kalra, Kimberly Long, Alan Buckler
  • CONVERTIBLE UMBRELLA PURSE
    Publication number: 20160227891
    Abstract: The present invention is an apparatus that is a purse, which can convert into an integrated umbrella. A clutch may be removably disposed in the purse.
    Type: Application
    Filed: February 5, 2015
    Publication date: August 11, 2016
    Inventors: Danielle Sanchez, Kimberly Long